Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer

Cancer

Volumn 117, Issue 5, 2011, Pages 1103-

  Hermelink, Kerstin ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE DISEASE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; COGNITIVE DEFECT; DRUG SAFETY; FEMALE; HUMAN; LETTER; MENTAL PERFORMANCE; NEUROPSYCHOLOGICAL TEST; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRIORITY JOURNAL;

EID: 79952017839     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25708     Document Type: Letter

References (4)

1. Wefel JS, Saleeba AK, Buzdar AU, Meyers CA. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer. 2010;116:3348-3356.
2. McCaffrey RJ, Duff K, Westervelt HJ. Practitioner's Guide to Evaluating Change with Neuropsychological Assessment Instruments. New York: Kluwer Academic/Plenum Publishers; 2000.
3. Maruff P, Falleti MG, Collie A. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma. Results of a prospective, randomized, longitudinal trial. Cancer. 2004;101:2143-2144; author reply 2144-2145.
4. Ioannidis JP. Why most published research findings are false. PLoS Med. 2005;2:e124.